Literature DB >> 16518566

NMR assignment and secondary structure determination of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4.

Lorna C Waters1, Maret Böhm, Vaclav Veverka, Frederick W Muskett, Thomas A Frenkiel, Geoffrey P Kelly, Andrew Prescott, Nuvjeevan S Dosanjh, Karl-Heinz Klempnauer, Mark D Carr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16518566     DOI： 10.1007/s10858-005-5887-6

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN： 0925-2738            Impact factor:   2.835


× No keyword cloud information.
  2 in total

1.  The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.

Authors:  Hsin-Sheng Yang; Aaron P Jansen; Anton A Komar; Xiaojing Zheng; William C Merrick; Sylvain Costes; Stephen J Lockett; Nahum Sonenberg; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

2.  Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation.

Authors:  J L Cmarik; H Min; G Hegamyer; S Zhan; M Kulesz-Martin; H Yoshinaga; S Matsuhashi; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205
  2 in total
  6 in total

1.  Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation.

Authors:  Vaclav Veverka; Alistair J Henry; Patrick M Slocombe; Andrew Ventom; Barbara Mulloy; Frederick W Muskett; Mariusz Muzylak; Kevin Greenslade; Adrian Moore; Li Zhang; Jianhua Gong; Xueming Qian; Chris Paszty; Richard J Taylor; Martyn K Robinson; Mark D Carr
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

2.  Structural basis for inhibition of translation by the tumor suppressor Pdcd4.

Authors:  Nicole LaRonde-LeBlanc; Arti N Santhanam; Alyson R Baker; Alexander Wlodawer; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

3.  Conservation of functional sites on interleukin-6 and implications for evolution of signaling complex assembly and therapeutic intervention.

Authors:  Vaclav Veverka; Terry Baker; Nicholas T Redpath; Bruce Carrington; Frederick W Muskett; Richard J Taylor; Alastair D G Lawson; Alistair J Henry; Mark D Carr
Journal:  J Biol Chem       Date:  2012-10-01       Impact factor: 5.157

4.  Resonance assignment and secondary structure of the middle MA-3 domain and complete tandem MA-3 region of the tumour suppressor protein Pdcd4.

Authors:  Lorna C Waters; Ojore Oka; Frederick W Muskett; Sarah L Strong; Thore Schmedt; Karl-Heinz Klempnauer; Mark D Carr
Journal:  Biomol NMR Assign       Date:  2009-12-19       Impact factor: 0.746

5.  Structure and interactions of the human programmed cell death 1 receptor.

Authors:  Xiaoxiao Cheng; Vaclav Veverka; Anand Radhakrishnan; Lorna C Waters; Frederick W Muskett; Sara H Morgan; Jiandong Huo; Chao Yu; Edward J Evans; Alasdair J Leslie; Meryn Griffiths; Colin Stubberfield; Robert Griffin; Alistair J Henry; Andreas Jansson; John E Ladbury; Shinji Ikemizu; Mark D Carr; Simon J Davis
Journal:  J Biol Chem       Date:  2013-02-15       Impact factor: 5.157

6.  Structure of the tandem MA-3 region of Pdcd4 protein and characterization of its interactions with eIF4A and eIF4G: molecular mechanisms of a tumor suppressor.

Authors:  Lorna C Waters; Sarah L Strong; Eva Ferlemann; Ojore Oka; Frederick W Muskett; Vaclav Veverka; Sreemoti Banerjee; Thore Schmedt; Alistair J Henry; Karl-Heinz Klempnauer; Mark D Carr
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.